Along the same vein, platelets have been extensively shown to suppress CD8 + T cell immunity in the context of TGF-β signaling via GARP and actively promote cancer progression and aggressiveness, but can be targeted in vivo to enhance tumor control [61, 65, 71]. This evidence concerns the gene TGFB1 and neoplasm.